Notable Upgrades: Amazon.com (AMZN), eBay (EBAY), Zogenix (ZGNX), PTC Therapeutics (PTCT), Facebook (FB)

Amazon.com Inc. (AMZN) was reiterated a ‘Buy’ by Nomura analysts on Wednesday. The broker also raised its price target on the stock to $500 from $490.

AMZN shares recently lost $2.22 to $463.35. In the past 52 weeks, shares of Seattle, Washington-based online retailer have traded between a low of $284.00 and a high of $469.60. Shares are up 31.03% year-over-year and 50.01% year-to-date.

eBay Inc. (EBAY) was reiterated as ‘Buy’ with a $71 from $62 price target on Wednesday by The Benchmark Company. The broker notes eBay is set to report 2Q/15 results tomorrow before the open. Investors are largely expected to ignore results, focusing instead on the complexities of the impending spin-off of PayPal (PYPL) due on Friday.

EBAY shares recently gained $0.39 to $63.98. The stock is up more than 24% year-over-year and has gained roughly 13.30% year-to-date. In the past 52 weeks, shares of San Jose, California-based company have traded between a low of $46.34 and a high of $64.29.

eBay Inc. closed Tuesday at $63.59. The name has a current market cap of $77.72 billion.

Zogenix, Inc. (ZGNX) rating of ‘Buy’ was reiterated today at Brean Capital with a price target increase of $28 from $20 (versus a $17.69 previous close).

On valuation measures, Zogenix Inc. shares are currently priced at 55.55x this year’s forecasted earnings. Ticker has a PEG and price/sales ratio of -0.19 and 8.98, respectively. EPS is $0.37. Currently there are 5 analysts that rate ZGNX a ‘Buy‘, 1 rates it a ‘Hold‘. No analyst rates it a ‘Sell‘. ZGNX has a median Wall Street price target of $20.00 with a high target of $28.00.

PTC Therapeutics, Inc. (PTCT) was raised to ‘Overweight‘ from ‘Neutral‘ at JP Morgan (JPM) on Wednesday.

PTCT is up $7.07 at $56.01 on heavy volume. Midway through trading Wednesday, 1.15 million shares of PTC Therapeutics Inc. have exchanged hands as compared to its average daily volume of 542K shares. The stock has ranged in a price between $51.74 to $57.20 after having opened the day at $53.46 as compared to the previous trading day’s close of $48.94.

In the past 52 weeks, shares of South Plainfield, New Jersey-based company have traded between a low of $22.70 and a high of $78.72. Shares are up 99.10% year-over-year ; down 5.47% year-to-date.

Facebook (FB) – The social networking giant had this morning its price target raised to $110 at Morgan Stanley (MS) based on scale and improving products. Morgan said its mobile ad checks indicate Facebook is still the mobile industry leader, has low pricing and high ad return on invetsment, and continues to pull in a larger share of ad budgets and ad dollars per MAU.

On valuation measures, Facebook Inc. Cl A shares are priced at 87.59x this year’s forecasted earnings, compared to the industry’s 21.89x earnings multiple. The company’s current year and next year EPS growth estimates stand at 13.00% and 32.50% compared to the industry growth rates of 16.90% and 23.40%, respectively. FB has a t-12 price-to-sales ratio of 18.65. EPS for the same period registers at $1.03.

Facebook shares have advanced 10% in the last 4 weeks and 7.38% in the past three months. Over the past 5 trading sessions the stock has gained 2.82%.

The Menlo Park, California-based company, which is currently valued at $253.61 billion, has a median Wall Street price target of $96.00 with a high target of $120.00. FB is up 32.08% year-over-year, compared with a 6.43% gain in the S&P 500.

Be the first to comment

Leave a Reply

Your email address will not be published.


*